Group | ADT n = 15 | Control n = 15 |
---|
Age | 69.0 ± 5.3 y | 66.1 ± 6.2 y |
Education | 9th grade: 1 | 9th grade: 1 |
| High School/GED: 5 | High School/GED: 5 |
| College 1-3 years: 3 | College 1-3 years: 3 |
| College graduate: 2 | College graduate: 3 |
| Post-graduate: 4 | Post-graduate: 3 |
MMSE | 29.0 ± 1.3 | 29.5 ± 0.6 |
Cancer staging | Stage II: 13 | Stage I: 1 |
| Stage III: 2 | Stage II: 12 |
| | Stage III: 2 |
Local therapy | Radiation 100% | Radiation 26.7% |
| | Surgery 66.7% |
| | Surgery + Radiation 6.7% |
QOL at baseline | 115 ± 22 | 132 ± 18 |
QOL of life at 6 months | 110 ± 23 | 128 ± 21 |
Testosterone at 6 months | 0.14 ± 0.10 ng/ml | 2.84 ± 0.94 ng/ml |
- Note: ADT: Androgen Deprivation Therapy; GED: General Education Development Test; MMSE: Mini Mental State Examination; QOL: FACT-P quality of life score; there is no difference between groups in age (t = 1.172, p = 0.588, two-sided two-sample t test); there is no difference between groups in MMSE score (t = 1.417, p = 0.167, two-sided two-sample t test); staging follows the current guidelines of the 2010 American Joint Committee on Cancer (AJCC) that include Gleason score in the staging; there is also no difference across the two time points in the change of QOL between groups (F = 0.056, p = 0.814, interaction, repeated measures analysis of variance).